Results that
speak clearly.
Named where the deal is public, anonymised where it is not — matters where our counsel made a measurable difference.
Counsel to the selling shareholder
alongside Carnelutti Law Firm
AXA acquires 51% of Prima Assicurazioni
AXA agreed to acquire 51% of Prima Assicurazioni, Italy's leading direct insurance distributor, with call and put options over the remaining 49%. We advised Neurone Capital Limited, the holding company that remains a significant shareholder in Prima.
Counsel to the Riva family and its companies
Settlement between Ilva and the Riva family
A multi-jurisdiction matter spanning litigation, insolvency, corporate reorganisation and board-member liability in the steel industry. Ilva and the Riva group withdrew their mutual proceedings, with the group making €1.33 billion available to Ilva for environmental remediation and continuing operations.
Counsel on the round
alongside BonelliErede
Two investment rounds for Cleafy
Cleafy builds proactive fraud-prevention technology for digital banking. We acted on its €10 million investment round — the second of two successive rounds we have advised on.
Counsel on the carve-out
alongside Latham & Watkins, Pessi
Sale of a Neptuny business branch to BMC
The carve-out and sale of a Neptuny business branch to BMC, the US software group — a cross-border transfer of a going concern together with its technology assets.
TopLegalLatham, Pessi e Longhini nella cessione di un ramo di Neptuny a BMC ↗Sale of Arduino SA to Qualcomm Technologies
We acted as legal counsel to Arduino SA, the Italian/Swiss target, through all stages of its sale to the US technology group Qualcomm Technologies — a transaction valued at approximately €400 million.
Northern Italy Waste-to-Energy Plant — Project Financing
We advise the sponsoring company on a project financing transaction for the construction of a waste-to-energy plant in Northern Italy, with an associated concession valued at €994 million. The mandate has been running since 2023.
CIETAC Arbitration Against a Chinese Public Company
Represented an Italian company before the China International Economic and Trade Arbitration Commission (CIETAC) in a dispute with a public Chinese company. The tribunal issued a favourable arbitral award for our client.
European Chemicals Agency Appeal
Successfully represented an Italian specialty chemicals producer before the Board of Appeal of the European Chemicals Agency (ECHA) in Helsinki, overturning a registration decision that would have restricted the client’s core product line across the EU.
Estonian Waste-to-Energy Plant — Turnkey Construction
Advising an Italian-German energy group on a turnkey construction project in Estonia for incineration plants with thermal recovery from hazardous waste, coordinating across Italian, German, and Estonian regulatory regimes.
Cross-Border Trademark Enforcement
Acting in a cross-border trademark infringement dispute for a technology company whose brand was misappropriated across three European jurisdictions. Coordinated enforcement actions in Italy, Germany, and the Netherlands, securing preliminary injunctions in all three forums.
Medical Malpractice — Landmark Annuity Ruling
Represented the plaintiff in a medical negligence case that changed Italian law on lifetime annuity awards. The court’s decision established a new precedent for the calculation of lifelong compensation in cases of severe, permanent injury — now cited across Italian civil courts.
Online Wine Distributor — Strategic Acquisition
Advised one of Italy's leading online wine distributors on an acquisition transaction, working alongside the client's team from negotiation through to closing.
Trade Secrets Litigation — IT Sector
Engaged in multi-layered litigation on behalf of an Italian technology group in matters of unfair competition and trade secret misappropriation. Obtained preliminary injunctions protecting proprietary software and customer data before the Milan Enterprise Court.
COVID-19 Hospital Liability Claims
Advising patients and families in medical liability claims arising from the COVID-19 pandemic, focusing on cases where hospital protocols, resource allocation decisions, and clinical management fell below the standard of care during the health emergency.